Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.

Karass M, Bareja R, Shelkey E, Vlachostergios PJ, Robinson BD, Khani F, Mosquera JM, Scherr DS, Sboner A, Tagawa ST, Molina AM, Elemento O, Nanus DM, Faltas BM.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):194-200. doi: 10.6004/jnccn.2018.7264.

PMID:
30865916
2.

Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?

Taylor BL, Matrai CE, Smith AL, Ayangbesan A, Xia L, Golombos DM, Mosquera JM, Nicolas J, Robinson BD, Scherr DS, Khani F.

Clin Genitourin Cancer. 2019 Feb;17(1):e209-e215. doi: 10.1016/j.clgc.2018.10.009. Epub 2018 Oct 29.

PMID:
30470630
3.

Hotspot enumeration of CD8+ tumor infiltrating lymphocyte using digital image analysis in triple negative breast Cancer yields consistent results.

McIntire PJ, Zhong E, Patel A, Khani F, D'Alfonso T, Chen Z, Shin SJ, Ginter PS.

Hum Pathol. 2018 Oct 28. pii: S0046-8177(18)30411-8. doi: 10.1016/j.humpath.2018.10.014. [Epub ahead of print]

PMID:
30381263
4.

Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.

Jain M, Robinson BD, Wu B, Khani F, Mukherjee S.

Arch Pathol Lab Med. 2018 Mar;142(3):383-390. doi: 10.5858/arpa.2017-0056-OA. Epub 2017 Dec 8.

PMID:
29219617
5.

Population-based study of the incidence and survival for intraductal carcinoma of the prostate.

Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, Hu JC.

Urol Oncol. 2017 Dec;35(12):673.e9-673.e14. doi: 10.1016/j.urolonc.2017.08.015. Epub 2017 Sep 14.

PMID:
28919182
6.

A Precious Diagnostic "Pearl": The Necklace Pattern in Germ Cell Tumors of the Testis.

Snow J, Mosquera JM, Scognamiglio T, Robinson BD, Khani F.

Int J Surg Pathol. 2018 Apr;26(2):148-150. doi: 10.1177/1066896917729502. Epub 2017 Sep 1.

PMID:
28862048
7.

Precursor Lesions of Urologic Malignancies.

Khani F, Robinson BD.

Arch Pathol Lab Med. 2017 Dec;141(12):1615-1632. doi: 10.5858/arpa.2016-0515-RA. Epub 2017 Aug 2. Review.

PMID:
28767283
8.

Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.

Rieken M, Shariat SF, Karam JA, Foerster B, Khani F, Gust K, Abufaraj M, Wood CG, Weizer AZ, Raman JD, Guo CC, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Bachmann A, De Marzo AM, Robinson BD, Margulis V.

J Urol. 2017 Dec;198(6):1269-1277. doi: 10.1016/j.juro.2017.06.096. Epub 2017 Jul 12.

PMID:
28709887
9.

Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.

Huang FW, Mosquera JM, Garofalo A, Oh C, Baco M, Amin-Mansour A, Rabasha B, Bahl S, Mullane SA, Robinson BD, Aldubayan S, Khani F, Karir B, Kim E, Chimene-Weiss J, Hofree M, Romanel A, Osborne JR, Kim JW, Azabdaftari G, Woloszynska-Read A, Sfanos K, De Marzo AM, Demichelis F, Gabriel S, Van Allen EM, Mesirov J, Tamayo P, Rubin MA, Powell IJ, Garraway LA.

Cancer Discov. 2017 Sep;7(9):973-983. doi: 10.1158/2159-8290.CD-16-0960. Epub 2017 May 17.

10.

Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence.

Dinerman BF, Bernstein AN, Khani F, Hu JC.

Urology. 2017 Jul;105:e1-e2. doi: 10.1016/j.urology.2017.03.030. Epub 2017 Mar 28.

PMID:
28363741
11.

Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors.

Meliti A, Sadimin E, Diolombi M, Khani F, Epstein JI.

Prostate. 2017 May;77(6):681-685. doi: 10.1002/pros.23314. Epub 2017 Feb 3.

PMID:
28155999
12.

In response to 'a plea for greater standardization' in intraductal carcinoma of the prostate: greater standardization requires greater evidence.

Khani F, Epstein JI.

Histopathology. 2017 May;70(6):1011-1013. doi: 10.1111/his.13147. Epub 2017 Feb 9. No abstract available.

PMID:
27943359
13.

Interobserver Reproducibility of Percent Gleason Pattern 4 in Prostatic Adenocarcinoma on Prostate Biopsies.

Sadimin ET, Khani F, Diolombi M, Meliti A, Epstein JI.

Am J Surg Pathol. 2016 Dec;40(12):1686-1692.

PMID:
27487740
14.

Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma.

Khani F, Diolombi ML, Khattar P, Huang W, Fallon JT, Epstein JI, Zhong M.

Am J Surg Pathol. 2016 Sep;40(9):1291-5. doi: 10.1097/PAS.0000000000000680.

PMID:
27299795
15.

Diagnostic dilemmas in enlarged and diffusely hemorrhagic adrenal glands.

Diolombi ML, Khani F, Epstein JI.

Hum Pathol. 2016 Jul;53:63-72. doi: 10.1016/j.humpath.2016.02.017. Epub 2016 Mar 18.

PMID:
27001431
16.

Iatrogenic Extraprostatic Extension of Prostate Cancer From a Needle Biopsy.

Johnson MH, Khani F, Schaeffer EM.

Urol Case Rep. 2015 Mar 14;3(3):56-8. doi: 10.1016/j.eucr.2015.01.011. eCollection 2015 May.

17.

A "Chicken or Egg" Conundrum: Race, Molecular Subtype, and Tumor Location in Prostate Cancer.

Khani F, Robinson BD.

Eur Urol. 2016 Jul;70(1):18-20. doi: 10.1016/j.eururo.2015.11.012. Epub 2015 Nov 26. No abstract available.

PMID:
26626619
18.

Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.

Schwartz LE, Khani F, Bishop JA, Vang R, Epstein JI.

Am J Surg Pathol. 2016 Jan;40(1):27-35. doi: 10.1097/PAS.0000000000000524.

PMID:
26426382
19.

Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.

Khani F, Epstein JI.

Am J Surg Pathol. 2015 Oct;39(10):1383-9. doi: 10.1097/PAS.0000000000000465.

PMID:
26076065
20.

Evidence for molecular differences in prostate cancer between African American and Caucasian men.

Khani F, Mosquera JM, Park K, Blattner M, O'Reilly C, MacDonald TY, Chen Z, Srivastava A, Tewari AK, Barbieri CE, Rubin MA, Robinson BD.

Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.

21.

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

Blattner M, Lee DJ, O'Reilly C, Park K, MacDonald TY, Khani F, Turner KR, Chiu YL, Wild PJ, Dolgalev I, Heguy A, Sboner A, Ramazangolu S, Hieronymus H, Sawyers C, Tewari AK, Moch H, Yoon GS, Known YC, Andrén O, Fall K, Demichelis F, Mosquera JM, Robinson BD, Barbieri CE, Rubin MA.

Neoplasia. 2014 Jan;16(1):14-20.

22.

Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.

Lee DJ, Xylinas E, Rieken M, Khani F, Klatte T, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Guo CC, Rioux-Leclercq N, Haitel A, Bolenz C, Bensalah K, Sagalowsky AI, Montorsi F, Lotan Y, Shariat SF, Robinson BD, Margulis V.

Eur Urol. 2014 Aug;66(2):379-85. doi: 10.1016/j.eururo.2013.12.008. Epub 2013 Dec 25.

PMID:
24388440
23.

Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder.

Xylinas E, Cha EK, Khani F, Kluth LA, Rieken M, Volkmer BG, Hautmann R, Küfer R, Chen YT, Zerbib M, Rubin MA, Scherr DS, Shariat SF, Robinson BD.

J Urol. 2014 Mar;191(3):830-41. doi: 10.1016/j.juro.2013.08.048. Epub 2013 Aug 28.

PMID:
23994370
24.

Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing.

Tewari AK, Ali A, Metgud S, Theckumparampil N, Srivastava A, Khani F, Robinson BD, Gumpeni N, Shevchuk MM, Durand M, Sooriakumaran P, Li J, Leung R, Peyser A, Gruschow S, Asija V, Harneja N.

World J Urol. 2013 Jun;31(3):471-80. doi: 10.1007/s00345-012-1018-7. Epub 2013 Jan 26.

PMID:
23354288
25.

A 24-year-old man with previously diagnosed hemophilia.

Khani F, Roshal M.

Clin Chem. 2012 Jul;58(7):1086-9. doi: 10.1373/clinchem.2011.166728. No abstract available.

26.

Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells.

Swaims AY, Khani F, Zhang Y, Roberts AI, Devadas S, Shi Y, Rabson AB.

Blood. 2010 Oct 21;116(16):2994-3003. doi: 10.1182/blood-2009-07-231050. Epub 2010 Jul 15.

Supplemental Content

Loading ...
Support Center